Skip to main content
Ted Morton, PharmD, BCIDP

Ted Morton, PharmD, BCIDP

  • Infectious Diseases Pharmacy Residency Director
  • Professor, The University of Tennessee Health Sciences Center, Department of Clinical Pharmacy and Translational Science

Board Certification

  • BCIDP

Education

PharmD – University of Florida, Gainesville, Florida

Post-Graduate Training

  • PGY1 Pharmacy Practice Residency – Regional One Healthcare, Memphis, Tennessee

Focused Area of Practice

  • Antimicrobial Stewardship / Infectious Diseases
  • Clinical Education and Training

Honors/Awards

  • 2024 "Living Our Values" award recipient, St. Jude Children's Research Hospital
  • 2020  Clinical Care Improvement Award for Clinical Pharmacy Services, St. Jude Children’s Research Hospital 
  • 2018  Innovative Practice Award (Team Member), Tennessee Society of Health-System Pharmacists
  • 2005  Excellence in Teaching Award, College of Pharmacy – Student Government Association Executive Council of the University of Tennessee Health Science Center
  • 2005  Teacher of the Year Award, P-2 class, University of Tennessee College of Pharmacy
  • 2005  Residents’ Choice Award, University of Tennessee Department of Medicine Residency Program
  • 2004  Preceptor of the Year, University of Tennessee College of Pharmacy
  • 2003  Pharmacist of the Year, Tennessee Society of Health-System Pharmacy

Research Interest

  • Antimicrobial Stewardship

St. Jude Committee Service

  • Antimicrobial Utilization and Improvement Committee
  • Infection Prevention and Control Committee
  • Residency Advisory Committee

Pharmacy Organizations/Committee Service

  • American College of Clinical Pharmacy
  • American Society of Health-System Pharmacists
  • MidSouth College of Clinical Pharmacy
  • Pediatric Infectious Diseases Society
  • Society of Infectious Diseases Pharmacists
  • Tennessee Pharmacists Association and Tennessee Society of Hospital Pharmacists

Selected Publications

King MA, Cross SJ, Morton TH, Hijano DR, Greene WL, Sun Y, Tang L, Pauley JL, Bourque MS, Christensen AM. Evaluation of Continuous Infusion Vancomycin in a Pediatric Hematology/Oncology Population. Pediatr Infect Dis J. 2024 Jun 1;43(6):520-524. doi: 10.1097/INF.0000000000004278. Epub 2024 Feb 12. PMID: 38359358; PMCID: PMC11098708.

Willis ZI, Oliveira CR, Abzug MJ, Anosike BI, Ardura MI, Bio LL, Boguniewicz J, Chiotos K, Downes K, Grapentine SP, Hersh AL, Heston SM, Hijano DR, Huskins WC, James SH, Jones S, Lockowitz CR, Lloyd EC, MacBrayne C, Maron GM, Hayes McDonough M, Miller CM, Morton TH, Olivero RM, Orscheln RC, Schwenk HT, Singh P, Soma VL, Sue PK, Vora SB, Nakamura MM, Wolf J. Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce. J Pediatric Infect Dis Soc. 2024 Mar 19;13(3):159-185. doi: 10.1093/jpids/piad116. PMID: 38339996.

Shapiro K, Cross SJ, Morton TH, Inaba H, Holland A, Fasipe FR, Adderson EE. Healthcare-Associated Infections Caused by Mycolicibacterium neoaurum. Emerg Infect Dis. 2023 Aug;29(8):1516–23. doi: 10.3201/eid2908.230007. PMID: 37486155; PMCID: PMC10370869.

Hijano DR, Ferrolino JA, Swift EG, Michaels CA, Max A, Hayden RT, Wolf J, Dallas RH, Greene WL, Richardson JL, Hakim H, Morton TH, Cross SJ. SARS-CoV-2 infection in high-risk children following tixagevimab-cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study. Front Oncol. 2023 Aug 3;13:1229655. PMID: 37601666 

Swanson HD, Hakim H, Hijano DR, Morton T, Cross S, Inaba H, Jeha S, Pui CH, Karol SE. Vaccines against SARS-CoV-2 are safe to administer in patients with antibodies to pegaspargase. Cancer Med. 2023 Jan;12(2):1552-1555. doi: 10.1002/cam4.5011. Epub 2022 Jul 15. PMID: 35837830; PMCID: PMC9349948. 

Wolf J, Abzug MJ, Anosike BI, Vora SB, Waghmare A, Sue PK, Olivero RM, Oliveira CR, James SH, Morton TH, Maron GM, Young JL, Orscheln RC, Schwenk HT, Bio LL, Willis ZI, Lloyd EC, Hersh AL, Huskins CW, Soma VL, Ratner AJ, Hayes M, Downes K, Chiotos K, Grapentine SP, Wattier RL, Lamb GS, Zachariah P, Nakamura MM. Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents. J Pediatric Infect Dis Soc. 2022 May 30;11(5):177-185. PMID: 35107571

Cross SJ, Morton TH, Wolf J. Epidemiology, Diagnosis, and Treatment of Clostridioides difficile Infection in Immunocompromised Children. J Pediatric Infect Dis Soc. 2021 Nov 17;10(Supplement_3):S46-S51. doi: 10.1093/jpids/piab078. PMID: 34791397; PMCID: PMC8824809. 

Wolf J, Abzug MJ, Wattier RL, Sue PK, Vora SB, Zachariah P, Dulek DE, Waghmare A, Olivero R, Downes KJ, James SH, Pinninti SG, Yarbrough A, Aldrich ML, MacBrayne CE, Soma VL, Grapentine SP, Oliveira CR, Hayes M, Kimberlin DW, Jones SB, Bio LL, Morton TH, Hankins JS, Maron GM, Timberlake K, Young JL, Orscheln RC, Schwenk HT, Goldman DL, Groves HE, Huskins WC, Rajapakse NS, Lamb GS, Tribble AC, Lloyd EC, Hersh AL, Thorell EA, Ratner AJ, Chiotos K, Nakamura MM. Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents. J Pediatric Infect Dis Soc. 2021 May 28;10(5):629-634. doi: 10.1093/jpids/piaa175. PMID: 33388760; PMCID: PMC7799019.

Dove ML, Jaggi P, Kelleman M, Abuali M, Ang JY, Ballan W, Basu SK, Campbell MJ, Chikkabyrappa SM, Choueiter NF, Clouser KN, Corwin D, Edwards A, Gertz SJ, Ghassemzadeh R, Jarrah RJ, Katz SE, Knutson SM, Kuebler JD, Lighter J, Mikesell C, Mongkolrattanothai K, Morton T, Nakra NA, Olivero R, Osborne CM, Panesar LE, Parsons S, Patel RM, Schuette J, Thacker D, Tremoulet AH, Vidwan NK, Oster ME. Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management. J Pediatr. 2021 Feb;229:33-40. doi: 10.1016/j.jpeds.2020.10.026. Epub 2020 Oct 16. PMID: 33075369; PMCID: PMC7566788.

Last update: October 2024

Close